Jnana Therapeutics
Stuart Schreiber is a founding core member of the Broad Institute since 2003. He was the founding director in 1997 of Harvard’s Institute of Chemistry and Cell Biology, which provided the origins of the Broad Institute’s Chemical Biology Program and which has since been incorporated into the Chemical Biology and Therapeutic Sciences (CBTS) Program.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Jnana Therapeutics
1 followers
Jnana is building the first drug discovery platform dedicated to SLC transporters. This proprietary chemistry and biology platform allows the company to rapidly and comprehensively address therapeutic targets across the greater the 400-member membrane protein family